Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
5.27
+0.57 (12.13%)
At close: May 12, 2025, 4:00 PM
5.27
0.00 (0.00%)
After-hours: May 12, 2025, 6:11 PM EDT
CPIX Revenue
Cumberland Pharmaceuticals had revenue of $11.71M in the quarter ending March 31, 2025, with 37.84% growth. This brings the company's revenue in the last twelve months to $41.08M, up 5.82% year-over-year. In the year 2024, Cumberland Pharmaceuticals had annual revenue of $37.87M, down -4.26%.
Revenue (ttm)
$41.08M
Revenue Growth
+5.82%
P/S Ratio
1.83
Revenue / Employee
$451,465
Employees
91
Market Cap
78.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.87M | -1.68M | -4.26% |
Dec 31, 2023 | 39.55M | -2.46M | -5.85% |
Dec 31, 2022 | 42.01M | 6.03M | 16.75% |
Dec 31, 2021 | 35.99M | -1.46M | -3.89% |
Dec 31, 2020 | 37.44M | 3.05M | 8.88% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CPIX News
- 2 days ago - Cumberland Pharmaceuticals, Inc. (CPIX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025 - PRNewsWire
- 13 days ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE - PRNewsWire
- 7 weeks ago - FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference - PRNewsWire
- 2 months ago - Cumberland Pharmaceuticals Inc. (CPIX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth - PRNewsWire
- 2 months ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - PRNewsWire